Abstract:Key PointsAtherothrombotic vascular disease (ATVD) is the leading cause of death in the industrialized world, and this problem is growing owing to the increase in obesity and insulin resistance worldwide. ATVD develops as a macrophage-dominant maladaptive inflammatory response to subendothelial lipoproteins.A fundamental aspect of this maladaptive inflammatory response is a failure to resolve inflammation, which normally involves the suppression of inflammatory cell influx, effective phagocytic clearance of apoptotic cells and promotion of inflammatory cell egress. The mechanism of failed inflammation resolution in atherosclerosis is not known, but it is likely to involve defective generation or action of anti-inflammatory cytokines (for example, interleukin-10), pro-resolution lipid mediators (for example, lipoxins) and transcription factors (for example, the liver X receptor family) that normally carry out this process.In advanced atherosclerosis, there is continual recruitment of inflammatory monocytes, and the macrophages that differentiate from these monocytes in lesions may favour the classically activated (M1) subtype, which promote inflammation, over the alternatively activated (M2) subtype, which participate in inflammation resolution. Egress of inflammatory macrophages in advanced atherosclerotic lesions is also defective.Macrophage apoptosis coupled with defective clearance of these apoptotic cells (efferocytosis) in advanced atherosclerotic lesions is a particularly important process because it leads to the generation of plaque necrosis, which is a key feature of the types of atherosclerotic lesions that cause ATVD. One key mechanism of macrophage apoptosis in this setting is a pathway in which the endoplasmic reticulum stress pathway known as the unfolded protein response, perhaps in combination with pattern recognition receptor activation, triggers Ca2+-dependent apoptosis.The mechanisms of defective efferocytosis in advanced atheroma are not known, but may involve deficiency, dysfunction and/or competitive inhibition of receptors, ligands and other factors involved in apoptotic cell recognition and engulfment.The ability to translate the complex process of plaque progression into an integrated molecular and cellular concept of defective inflammation resolution provides a useful way to understand how atherosclerosis leads to clinical disease and how plaque progression may be prevented by new therapeutic approaches.

Catastrophic Health Care Bill.

Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets

Mechanisms and consequences of macrophage apoptosis in atherosclerosis

Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis

Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation

Redistribution Of Intracellular Calcium And Its Effect On Apoptosis In Macrophages: Induction By Oxidized Ldl

Cell death in atherosclerosis

Macrophage death and defective inflammation resolution in atherosclerosis

Mechanism of efferocytosis in atherosclerosis

Macrophage Anti-inflammatory Behaviour in a Multiphase Model of Atherosclerotic Plaque Development

Macrophage Apoptosis Exerts Divergent Effects on Atherogenesis as a Function of Lesion Stage

Intracellular-free calcium dynamics and F-actin alteration in the formation of macrophage foam cells.

Programmed cell death in atherosclerosis and vascular calcification

Autophagy Plays a Protective Role in Free Cholesterol Overload-Induced Death of Smooth Muscle Cells

Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability

Drug-induced macrophage autophagy in atherosclerosis: for better or worse?

Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis

Autophagy is associated with cell fate in the process of macrophage-derived foam cells formation and progress

Macrophages and Foam Cells: Brief Overview of Their Role, Linkage, and Targeting Potential in Atherosclerosis

Novel insight on the role of Macrophages in atherosclerosis: Focus on polarization, apoptosis and efferocytosis